Logo image of CHCT

COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Analyst Earnings Estimates

NYSE:CHCT - New York Stock Exchange, Inc. - US20369C1062 - REIT

19.5  -0.69 (-3.42%)

After market: 19.5 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
CHCT revenue by date.CHCT revenue by date.
90.58M
19.69%
97.68M
7.84%
112.845M
15.53%
118.26M
4.80%
127.19M
7.55%
139.3M
9.52%
179.96M
29.19%
198.16M
10.11%
221M
11.53%
EBITDA
YoY % growth
CHCT ebitda by date.CHCT ebitda by date.
63.31M
18.78%
66.21M
4.58%
64.794M
-2.14%
86.119M
32.91%
93.454M
8.52%
N/AN/AN/AN/A
EBIT
YoY % growth
CHCT ebit by date.CHCT ebit by date.
32.91M
17.87%
33.87M
2.92%
25.101M
-25.89%
24.843M
-1.03%
32.687M
31.57%
43.859M
34.18%
53.789M
22.64%
62.386M
15.98%
71.258M
14.22%
Operating Margin
CHCT operating margin by date.CHCT operating margin by date.
36.33%34.67%22.24%21.01%25.70%31.49%29.89%31.48%32.24%
EPS
YoY % growth
CHCT eps by date.CHCT eps by date.
0.86
7.50%
0.82
-4.65%
0.18
-78.05%
-0.12
-168.00%
0.38
408.33%
0.53
40.54%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.07
-52.40%
0.08
-25.82%
0.09
359.00%
0.10
155.00%
0.11
57.14%
0.12
50.00%
0.13
44.44%
0.13
30.00%
0.14
27.27%
Revenue
Q2Q % growth
30.349M
4.21%
30.881M
5.28%
31.513M
14.53%
32.059M
8.16%
32.607M
7.44%
32.497M
5.23%
33.017M
4.77%
33.488M
4.46%
34.012M
4.31%
EBITDA
Q2Q % growth
22.069M
-55.18%
22.587M
18.95%
23.105M
-36.12%
23.622M
-40.61%
24.14M
9.38%
N/AN/AN/AN/A
EBIT
Q2Q % growth
6.437M
-32.60%
11.541M
32.26%
11.987M
-20.71%
12.192M
56.49%
12.478M
93.85%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
0.04
-63.64%
0.07-0.03-43.98%
Q2 2024
Q2Q % growth
0.02
-91.67%
0.15-0.13-86.93%
Q1 2024
Q2Q % growth
0.11
134.38%
0.18-0.07-40.09%
Q4 2023
Q2Q % growth
0.15
-21.05%
0.150.00-1.96%
Q3 2023
Q2Q % growth
0.11
-47.62%
0.25-0.14-55.98%
Q2 2023
Q2Q % growth
0.24
14.29%
0.210.0312.04%
Q1 2023
Q2Q % growth
-0.32
-252.38%
0.24-0.56-230.72%
Q4 2022
Q2Q % growth
0.19
-17.39%
0.25-0.06-23.97%
Q3 2022
Q2Q % growth
0.21
5.00%
0.25-0.04-15.97%
Q2 2022
Q2Q % growth
0.21
-4.55%
0.23-0.02-10.49%
Q1 2022
Q2Q % growth
0.21 0.25-0.04-15.97%
Q4 2021
Q2Q % growth
0.23
9.52%
0.26-0.02-9.80%
Q3 2021
Q2Q % growth
0.20
-9.09%
0.26-0.05-21.57%
Q2 2021
Q2Q % growth
0.22
15.79%
0.24-0.02-8.87%
Q1 2021
Q2Q % growth
0.21
16.67%
0.24-0.03-13.01%
Q4 2020
Q2Q % growth
0.21
133.33%
0.23-0.02-10.49%
Q3 2020
Q2Q % growth
0.22
83.33%
0.220.00-0.83%
Q2 2020
Q2Q % growth
0.19
111.11%
0.20-0.01-5.29%
Q1 2020
Q2Q % growth
0.18
200.00%
0.180.00-1.96%
Q4 2019
Q2Q % growth
0.09 0.15-0.06-41.18%
Q3 2019
Q2Q % growth
0.12 0.15-0.03-21.57%
Q2 2019
Q2Q % growth
0.09 0.11-0.02-15.97%
Q1 2019
Q2Q % growth
0.06 0.11-0.05-46.52%
CHCT Yearly EPS VS EstimatesCHCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 0.4 0.6 0.8
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
29.639M
3.15%
30.117M-478K-1.59%
Q2 2024
Q2Q % growth
27.516M
-1.06%
30.984M-3.468M-11.19%
Q1 2024
Q2Q % growth
29.333M
7.94%
30.219M-886K-2.93%
Q4 2023
Q2Q % growth
29.124M
14.93%
30.356M-1.232M-4.06%
Q3 2023
Q2Q % growth
28.735M
15.82%
29.444M-709K-2.41%
Q2 2023
Q2Q % growth
27.81M
15.63%
28.423M-613K-2.16%
Q1 2023
Q2Q % growth
27.176M
15.74%
27.105M71K0.26%
Q4 2022
Q2Q % growth
25.34M
9.04%
26.141M-801K-3.06%
Q3 2022
Q2Q % growth
24.81M
6.71%
24.916M-106K-0.43%
Q2 2022
Q2Q % growth
24.05M
5.99%
24.4M-350K-1.43%
Q1 2022
Q2Q % growth
23.48M
9.72%
24.288M-808K-3.33%
Q4 2021
Q2Q % growth
23.24M
15.51%
24.126M-886K-3.67%
Q3 2021
Q2Q % growth
23.25M
20.22%
23.133M117K0.51%
Q2 2021
Q2Q % growth
22.69M
24.12%
22.374M316K1.41%
Q1 2021
Q2Q % growth
21.4M
19.29%
21.14M260K1.23%
Q4 2020
Q2Q % growth
20.12M
19.55%
20.28M-160K-0.79%
Q3 2020
Q2Q % growth
19.34M
18.94%
19.037M303K1.59%
Q2 2020
Q2Q % growth
18.28M
27.65%
18.65M-370K-1.98%
Q1 2020
Q2Q % growth
17.94M
33.48%
18.002M-62K-0.34%
Q4 2019
Q2Q % growth
16.83M 17.402M-572K-3.29%
Q3 2019
Q2Q % growth
16.26M 15.904M356K2.24%
Q2 2019
Q2Q % growth
14.32M 14.782M-462K-3.13%
Q1 2019
Q2Q % growth
13.44M 13.817M-377K-2.73%
CHCT Yearly Revenue VS EstimatesCHCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -58.82% 0% -9.09%
Revenue0% -7.31% 0.13% -1.38%